Ask AI
ProCE Banner Series

HER2-Directed ADCs in Bladder Cancer: Strategies to Personalize Treatment Selection and Optimize Patient Outcomes

This live educational program is a satellite symposium associated with the 26th Annual Meeting of the Society of Urologic Oncology, occurring on December 2, 2025, at the Sheraton Phoenix Downtown, in Phoenix, Arizona. The faculty will discuss emerging clinical evidence in HER2+ bladder cancer and the potential impact of HER2-targeted antibody–drug conjugates for urologists, oncologists, and clinicians involved in the treatment of bladder cancer.

In conjunction with the SUO Annual Meeting.

  AMA
Who Should Attend

This activity has been designed to meet the educational needs of urologists, oncologists, and other healthcare professionals who care for patients with bladder cancer. 

All Events

HER2-Directed ADCs in Bladder Cancer: Strategies to Personalize Treatment Selection and Optimize Patient Outcomes

Upcoming Events

December

02

2025

7:15 AM - 8:30 AM Mountain Time (MT)

In-person

Sheraton Phoenix Downtown, 340 N 3rd St, Phoenix, Arizona 85004

7:30 AM - 8:30 AM Mountain Time (MT)

Virtual

Additional Info

There are no fees required to participate in this activity.

Americans With Disabilities Act
Event staff will be glad to assist you with any special needs (eg, physical, dietary). Please contact Customer Support prior to the live event.

CME/CE Info

Goal Statement
The goal of this activity is to improve the knowledge, confidence, and competence of urologists, oncologists and other healthcare professionals on the personalized integration of HER2 directed therapies into therapeutic plans that improve patient outcomes.

Target Audience
This activity has been designed to meet the educational needs of urologists, oncologists, and other healthcare professionals who care for patients with bladder cancer. 

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Assess HER2 alterations in patients with bladder cancer to guide individualized clinical decisions

  • Evaluate the latest efficacy and safety data for HER2-targeted ADCs in bladder cancer to inform personalized treatment plans and supportive care for treatment-related adverse events (TRAEs)

  • Formulate care strategies for HER2 expressing bladder cancer that are informed by available clinical evidence and expert recommendations

Accreditation

Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Physician Continuing Medical Education

CCO designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

American Board of Internal Medicine Maintenance of Certification

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 MOC point in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

For ABIM MOC points, your information will be shared with the ABIM through CCO's Joint Accreditation Program and Activity Reporting System (JAPARS). Please allow 6-8 weeks for your MOC points to appear on your ABIM records.

By sharing your Diplomate Board ID # and DOB, you are giving Clinical Care Options, LLC permission to use this information/data to report your participation to these Boards via the Joint Accreditation Program and Activity Reporting System (JA-PARS).

CME Passport

https://omni-channel-2022-assets-production.s3.amazonaws.com/editorupload/662be69741e7b.png

The CME credits that physicians earn from this activity will be submitted to ACCME's CME Passport, a free, centralized web application where you can create a personalized account to view, track, and generate transcripts of your reported CME credit. Visit www.cmepassport.org to create your account.

Disclosure of Conflicts of Interest
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

Acknowledgement

Provided by

Provided by Clinical Care Options, LLC

Clinical Care Options, LLC

Supporters

Supported by educational grants from AstraZeneca and Daiichi Sankyo, Inc.

AstraZeneca

Daiichi Sankyo, Inc.

For customer support please click here.

Mailing Address:

 

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 304
Reston, VA 20191